Use of Herbal Drugs in Cardiovascular Disease- A Review

Arshdeep Kaur1, Ranjeet Kumar1

  • 1Department of Pharmacy Practice, ISF College of Pharmacy, Moga, (Punjab), India.

Current Cardiology Reviews
|September 4, 2024
PubMed

Insights

Cardiovascular disorders (CVDs) cause 30% of global deaths. This review explores how phytochemicals from medicinal plants can help manage CVD risks and prevent disease progression.

Area of Science:

  • Pharmacology
  • Cardiology
  • Ethnobotany

Background:

  • Cardiovascular disorders (CVDs) are a leading cause of global mortality, accounting for 30% of all deaths.
  • WHO data indicates 17.9 million deaths annually, projected to rise to 22.2 million by 2030, with women disproportionately affected.
  • Phytochemicals, plant-derived compounds, are increasingly used as complementary or alternative treatments for CVD prevention and management.

Purpose of the Study:

  • To review the therapeutic applications of various herbal drugs for cardiovascular diseases.
  • To elucidate the mechanisms of action, active phytochemical constituents, and potential side effects of these herbal treatments.
  • To highlight the role of phytochemicals in mitigating cardiovascular risks.

Main Methods:

  • Literature review of medicinal plants and their phytochemicals used in cardiovascular disease management.
  • Analysis of scientific data on the efficacy and safety of herbal remedies for CVD.
  • Identification of key phytochemical compounds and their pharmacological actions.

Main Results:

  • Phytochemicals demonstrate efficacy in reducing cardiovascular risks, including lowering blood cholesterol, managing obesity and type 2 diabetes, controlling oxidative stress and inflammation, and inhibiting platelet aggregation.
  • Specific medicinal plants like ginseng, Ginkgo biloba, Ganoderma lucidum, Gynostemma pentaphyllum, and Amaranthus viridis are recognized for their CVD-treating properties.
  • Key active phytochemicals include plant sterols, flavonoids, polyphenols, sulfur compounds, and terpenoids.

Conclusions:

  • Herbal medicines and their phytochemicals offer a promising avenue for the prevention and treatment of cardiovascular diseases.
  • Further research is essential to fully understand the mechanisms and specific phytochemicals involved in plant-based CVD therapies.
  • Integrating evidence-based herbal treatments could enhance cardiovascular health outcomes.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.9K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741